Late-stage Parkinson's disease: The Barcelona and Lisbon cohort

Journal of Neurology

Volumn 257, Issue 9, 2010, Pages 1524-1532

  Coelho, Miguel ^a   Marti, Maria J ^b   Tolosa, Eduardo ^b   Ferreira, Joaquim J ^a   Valldeoriola, Francesc ^b   Rosa, Mário ^a   Sampaio, Cristina ^a  

^a HOSPITAL DE SANTA MARIA   (Portugal)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Dementia; Disability; Late stage; Motor fluctuations; Parkinson's disease

Indexed keywords

AMANTADINE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; ENTACAPONE; LEVODOPA; NEUROLEPTIC AGENT; RIVASTIGMINE; SELEGILINE;

ANTICHOLINERGIC EFFECT; ARTICLE; BRAIN SURGERY; DEMENTIA; DEPRESSION; DYSARTHRIA; DYSKINESIA; DYSPHAGIA; FEMALE; GAIT; HEALTH CARE PLANNING; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; PARKINSON DISEASE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QUESTIONNAIRE; SPAIN; TREMOR; VISUAL HALLUCINATION;

AGED; AGED, 80 AND OVER; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LEVODOPA; MALE; PARKINSON DISEASE; PORTUGAL; PREVALENCE; SEVERITY OF ILLNESS INDEX; SPAIN;

EID: 77957332171     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-010-5566-8     Document Type: Article

References (38)

1. WE Martin RB Loewenson JA Resch, et al. 1973 Parkinson's disease. Clinical analysis of 100 patients Neurology 23 783 790 1:STN:280: DyaE3s3it1Kiuw%3D%3D 4578348
2. S Papapetropoulos J Gonzalez A Lieberman, et al. 2005 Dementia in Parkinson's disease: a post-mortem study in a population of brain donors Int J Geriatr Psychiatry 20 418 422 10.1002/gps.1297 1:STN:280:DC%2BD2M3ivVKqsg%3D%3D 15852454 (Pubitemid 40716333)
3. D Aarsland JP Larsen JL Cummins, et al. 1999 Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study Arch Neurol 56 595 601 10.1001/archneur.56.5.595 1:STN:280:DyaK1M3lvVyjtQ%3D%3D 10328255 (Pubitemid 29218155)
4. MA Hely JG Morris WG Reid, et al. 2005 Sydney multicenter study of Parkinson's disease: non-l-dopa-responsive problems dominate at 15 years Mov Disord 20 190 199 10.1002/mds.20324 15551331 (Pubitemid 40361122)
5. MA Hely WG Reid MA Adena, et al. 2008 The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years Mov Disord 23 837 844 10.1002/mds.21956 18307261
6. CE Clarke 1993 Mortality from Parkinson's disease in England and Wales 1921-89 J Neurol Neurosurg Psychiatry 56 690 693 10.1136/jnnp.56.6.690 1:STN:280:DyaK3s3os1KisQ%3D%3D 8509785
7. AJ Hughes SE Daniel L Kilford, et al. 1992 Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases J Neurol Neurosurg Psychiatry 55 181 184 10.1136/jnnp.55.3.181 1:STN:280:DyaK383is1Omsg%3D%3D 1564476
8. MM Hoehn MD Yahr 1967 Parkinsonism: onset, progression and mortality Neurology 17 427 442 1:STN:280:DyaF2s7jvFSgsg%3D%3D 6067254
9. Fahn S, Elton RL (1987) Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne D, Goldstein M (eds) Recent developments in Parkinson's disease. Macmillan Healthcare Information, Florham Park, pp 153-163
10. RJ Uitti Y Baba NR Whaley, et al. 2005 Parkinson disease: handedness predicts asymmetry Neurology 64 1925 1930 10.1212/01.WNL.0000163993.82388.C8 1:STN:280:DC%2BD2MzgvFWltQ%3D%3D 15955945 (Pubitemid 40800708)
11. T Witjas E Kaphan JP Azulay, et al. 2002 Nonmotor fluctuations in Parkinson's disease: frequent and disabling Neurology 59 408 413 12177375
12. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington
13. MF Folstein SE Folstein PR McHugh 1975 Mini-mental state. A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 189 198 10.1016/0022-3956(75)90026-6 1:STN:280:DyaE28%2FntFKjtw%3D%3D 1202204
14. AT Beck CH Ward M Mendelson, et al. 1961 An inventory for measuring depression Arch Gen Psychiatry 4 561 571 1:STN:280:DyaF3c%2FgslKisg%3D%3D 13688369
15. BL Den Oudsten GL Van Heck J De Vries 2007 Quality of life and related concepts in Parkinson's disease: a systematic review Mov Disord 22 1528 1537 10.1002/mds.21567 (Pubitemid 47477911)
16. S Papapetropoulos DC Mash 2007 Motor fluctuations and dyskinesias in advanced/end stage Parkinson's disease: a study from a population of brain donors J Neural Transm 114 341 345 10.1007/s00702-006-0603-6 1:STN:280:DC%2BD2s7hsVeqsQ%3D%3D 17146589 (Pubitemid 46328661)
17. MA Hely JG Morris R Traficante, et al. 1999 The Sydney multicenter study of Parkinson's disease: progression and mortality at 10 years J Neurol Neurosurg Psychiatry 67 300 307 10.1136/jnnp.67.3.300 1:STN:280:DyaK1MzotVChsQ%3D%3D 10449550
18. AJ Hughes SE Daniel S Blankson, et al. 1993 A clinicopathologic study of 100 cases of Parkinson's disease Arch Neurol 50 140 148 1:STN:280: DyaK3s7lvFentA%3D%3D 8431132
19. RM Pickering YA Grimbergen U Rigney, et al. 2007 A meta-analysis of six prospective studies of falling in Parkinson's disease Mov Disord 22 1892 1900 10.1002/mds.21598 17588236 (Pubitemid 350134202)
20. J Muller GK Wenning M Verny, et al. 2001 Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders Arch Neurol 58 259 264 10.1001/archneur.58.2.259 1:STN:280:DC%2BD3M7ntFWksA%3D%3D 11176964
21. PA Kempster DR Williams M Selikhova, et al. 2007 Patterns of levodopa response in Parkinson's disease: a clinico-pathological study Brain 130 2123 2128 10.1093/brain/awm142 1:STN:280:DC%2BD2svksFCgsA%3D%3D 17586867 (Pubitemid 47236624)
22. D Aarsland JP Larsen NG Lim, et al. 1999 Range of neuropsychiatric disturbances in patients with Parkinson's disease J Neurol Neurosurg Psychiatry 67 492 496 10.1136/jnnp.67.4.492 1:STN:280:DyaK1MvhslOmsw%3D%3D 10486397 (Pubitemid 29438205)
23. D Aarsland K Bronnick U Ehrt, et al. 2007 Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress J Neurol Neurosurg Psychiatry 78 36 42 10.1136/jnnp.2005.083113 1:STN:280:DC%2BD28jjs1Sntw%3D%3D 16820421 (Pubitemid 46048261)
24. A Schrag P Barone RG Brown, et al. 2007 Depression rating scales in Parkinson's disease: critique and recommendations Mov Disord 22 1077 1092 10.1002/mds.21333 17394234 (Pubitemid 47067217)
25. G Fenelon F Mahieux R Huon, et al. 2000 Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors Brain 123 733 745 10.1093/brain/123.4.733 10734005
26. S Papapetropoulos AA Argyriou J Ellul 2005 Factors associated with drug-induced visual hallucinations in Parkinson's disease J Neurol 252 1223 1228 10.1007/s00415-005-0840-x 15834642 (Pubitemid 41443623)
27. D Aarsland K Andersen JP Larsen, et al. 2003 Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study Arch Neurol 60 387 392 10.1001/archneur.60.3.387 12633150 (Pubitemid 36314364)
28. C Marras P Rochon AE Lang 2002 Predicting motor decline and disability in Parkinson disease: a systematic review Arch Neurol 59 1724 1728 10.1001/archneur.59.11.1724 12433259 (Pubitemid 35340482)
29. WJ Zetusky J Jankovic FJ Pirozzolo 1985 The heterogeneity of Parkinson's disease: clinical and prognostic implications Neurology 35 522 526 1:STN:280:DyaL2M7msVajtA%3D%3D 3982637
30. N Giladi TA Treves D Paleacu, et al. 2000 Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease J Neural Transm 107 59 71 10.1007/s007020050005 1:STN:280:DC%2BD3c3mslCjsw%3D%3D 10809404
31. E Tandberg JP Larsen D Aarsland, et al. 1996 The occurrence of depression in Parkinson's disease a community-based study Arch Neurol 53 175 179 1:STN:280:DyaK283isFOiug%3D%3D 8639068
32. D Aarsland E Tandberg JP Larsen, et al. 1996 Frequency of dementia in Parkinson disease Arch Neurol 53 538 542 1:STN:280:DyaK283kt1Smtw%3D%3D 8660156
33. L Negre-Pages W Regragui D Bouhassira, et al. 2008 Chronic pain in Parkinson's disease: the cross-sectional French DoPaMiP survey Mov Disord 23 1361 1369 10.1002/mds.22142 18546344
34. G Defazio A Berardelli G Fabbrini, et al. 2008 Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study Arch Neurol 65 1191 1194 10.1001/archneurol.2008.2 18779422
35. P Krack A Batir N Van Blecom, et al. 2003 Five-year follow-up of bilateral stimulation of the sub-thalamic nucleus in advanced Parkinson's disease N Engl J Med 349 20 1925 1934 10.1056/NEJMoa035275 1:CAS:528: DC%2BD3sXptVGnurk%3D 14614167 (Pubitemid 37409709)
36. G Deuschl C Shade-Brittinger P Krack, et al. 2006 A randomized trial of deep-brain stimulation for Parkinson's disease N Engl J Med 355 9 896 908 10.1056/NEJMoa060281 1:CAS:528:DC%2BD28XovFCht70%3D 16943402 (Pubitemid 44315982)
37. H Braak K Del Tredici U Rub, et al. 2003 Staging of brain pathology related to sporadic Parkinson's disease Neurobiol Aging 24 197 211 10.1016/S0197-4580(02)00065-9 12498954 (Pubitemid 36007810)
38. H Apaydin JE Ahlskog JE Parisi, et al. 2002 Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response Arch Neurol 59 102 112 10.1001/archneur.59.1.102 11790237